Category : Search result: Zealand Pharma


India-NZ FTA Means More Jobs & Trade, Says PM Luxon

New Zealand PM Christopher Luxon highlights the India-New Zealand Free Trade Agreement's potential to create jobs, increase incomes, and boost bilateral trade. A landmark deal for economic partnership.

Aurobindo Pharma increases stake in China JV to 50%

Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.

India, NZ Conclude FTA Talks, Aim to Double Trade

India and New Zealand conclude historic Free Trade Agreement negotiations. Deal includes $20 bn NZ investment, visa pathways, and aims to double $1.3 bn bilateral trade in five years.

NZ Census: 'No Religion' Majority, Christian Numbers Decline

New Zealand's 2023 census reveals over 50% have 'No Religion' as Christian denominations decline. This follows a protest by a Pentecostal pastor against a Sikh Nagar Kirtan, drawing criticism from MPs. Sikh & Hindu populations grow.

India, NZ Announce FTA, Target $20B Investment

PM Modi & NZ's Christopher Luxon announce a historic free trade agreement concluded in 9 months. The deal aims to double bilateral trade in 5 years and attract $20B investment. Read more.

India & New Zealand Finalise FTA Negotiations

India and New Zealand have successfully concluded negotiations for a comprehensive Free Trade Agreement (FTA), boosting trade, investment, and cooperation. Discover the key highlights.

India Pharma Targets $500B, Innovation Hub by 2047

India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.

Page 1 of 4